Middle East & Africa Endothelial Dysfunction Market Forecast to 2028
Middle East & Africa Endothelial Dysfunction Market Forecast to 2028 – Regional Analysis – by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet’s Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Use of Non-invasive Methods to Assess Endothelial Dysfunction Fuels Middle East & Africa Endothelial Dysfunction Market
Endothelial dysfunction is a strong prognostic factor for cardiovascular events and mortality in the population. Assessment of endothelial function can aid in selecting therapies and assessing their response. While invasive angiography remains the gold standard for measuring coronary endothelial function, several noninvasive imaging techniques have evolved to study both coronary and peripheral endothelial function. Available endothelial testing methods are helpful for mechanistically understanding diseases and risk stratification and prognoses, such as high-resolution B-mode ultrasound and Doppler, computed tomography angiography, cardiovascular magnetic resonance (CMR), magnetic resonance imaging (MRI), and positron emission tomography (PET).
Noninvasive methods for assessing endothelial function are mainly used in scientific research since there is a significant risk of complications due to the specificity of endovascular interventions. One of the noninvasive methods to assess endothelial function is to measure fluorescence. Flow-mediated skin fluorescence (FMSF) is based on the fluorescence measurement of the reduced nicotinamide adenine dinucleotide (NADH) emitted by skin cells in response to UV light excitation. The test consists of three phases: recording the fluorescence’s background intensity, occlusion phase, and reaction registration. FMSF allows the determination of tissue and vascular bed response during ischemia, while classical Flow-Mediated Dilatation (FMD) techniques are based on a study of vasomotor reactivity. The classic FMD method for assessing the intensity of reactive hyperemia comprises three phases: measurement of the diameter of a selected artery (e.g., brachial artery), stimulation phase, and measurement after stimulation. Reactive peripheral arterial hyperemia tonometry (RH-PAT) is a modified FMD method used in EndoPAT devices. The method has been extensively validated in numerous publications as a diagnostic and predictive tool for assessing vascular risk. The closed zone FMD method (EZ-FMD) is based on oscillometric blood pressure measurement.
Middle East & Africa Endothelial Dysfunction Market Overview
Middle East & Africa consists of countries such as Saudi Arabia, the UAE, South Africa, and the Rest of Middle East. The growth of the market is attributed to increasing cases of chronic diseases that are primary factors or endothelial dysfunction, growing collaborations between governments to enhance healthcare facilities in South Africa, and growing incidences of obesity.
Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Endothelial Dysfunction Market Segmentation
The Middle East & Africa endothelial dysfunction market is segmented into cause, test type, end user, and country.
Based on cause, the Middle East & Africa endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet’s disease, and others. The hypertension segment registered the largest Middle East & Africa endothelial dysfunction market share in 2022.
Based on test type, the Middle East & Africa endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Middle East & Africa endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.
Based on end user, the Middle East & Africa endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Middle East & Africa endothelial dysfunction market share in 2022.
Based on country, the Middle East & Africa endothelial dysfunction market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa endothelial dysfunction market in 2022.
ZOLL Medical Corp, The Polymath Co, Perimed AB, SMART Medical Ltd, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the Middle East & Africa endothelial dysfunction market was valued at US$ 62.11 million in 2022 and is expected to reach US$ 75.11 million by 2028, registering a CAGR of 3.2% from 2022 to 2028. Increasing incidences of cardiovascular diseases and rising incidences of high cholesterol, diabetes and obesity are the critical factors attributed to the Middle East & Africa endothelial dysfunction market expansion.
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide.
According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Further, CVD deaths have increased by 48% over the past 30 years, which accounted for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized CVD mortality rates in the Middle East & North Africa ranged from 134.2 to 600.2 per 100,000 people.
Therefore, the high prevalence of cardiovascular diseases due to endothelial dysfunction drives the market.
On the contrary, disadvantages associated with the techniques for screening of endothelial dysfunction hurdles the growth of Middle East & Africa endothelial dysfunction market.
Based on cause, the Middle East & Africa endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet’s disease, and others. The hypertension segment held 32.7% share of Middle East & Africa endothelial dysfunction market in 2022, amassing US$ 20.33 million. It is projected to garner US$ 25.29 million by 2028 to expand at 3.7% CAGR during 2022-2028.
Based on test type, the Middle East & Africa endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held 74.0% share of Middle East & Africa endothelial dysfunction market in 2022, amassing US$ 45.98 million. It is projected to garner US$ 54.83 million by 2028 to expand at 3.0% CAGR during 2022-2028. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.
Based on end user, the Middle East & Africa endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held 52.0% share of Middle East & Africa endothelial dysfunction market in 2022, amassing US$ 32.32 million. It is projected to garner US$ 39.86 million by 2028 to expand at 3.6% CAGR during 2022-2028.
Based on country, the Middle East & Africa endothelial dysfunction market has been categorized into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 27.5% share of Middle East & Africa endothelial dysfunction market in 2022. It was assessed at US$ 17.07 million in 2022 and is likely to hit US$ 19.54 million by 2028, exhibiting a CAGR of 2.3% during 2022-2028.
Key players operating in the Middle East & Africa endothelial dysfunction are ZOLL Medical Corp, The Polymath Co, Perimed AB, SMART Medical Ltd, and Medizinische Messtechnik GmbH, among others.
In April 2023, Perimed has signed an agreement with Lovell Government Services. Lovell’s customers are Federal, State, and Local Governments such as the Department of Veteran Affairs (VA), Defense Logistics Agency, and Department of Defense in the United States. With this agreement, Perimed gains an additional sales channel as Lovell will notify the company of any government contract opportunities within its field of business and bid on Perimed’s behalf.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa endothelial dysfunction market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Endothelial Dysfunction Market – by Cause
1.3.2 Middle East & Africa Endothelial Dysfunction Market – by Test Type
1.3.3 Middle East & Africa Endothelial Dysfunction Market – by End User
1.3.4 Middle East & Africa Endothelial Dysfunction Market – by Country
2. Middle East & Africa Endothelial Dysfunction Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Endothelial Dysfunction Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East & Africa Endothelial Dysfunction Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of Cardiovascular Diseases
5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis
6. Endothelial Dysfunction Market – Middle East & Africa Analysis
6.1 Middle East & Africa Endothelial Dysfunction Market Revenue Forecast and Analysis
7. Middle East & Africa Endothelial Dysfunction Market Analysis – by Cause
7.1 Overview
7.2 Middle East & Africa Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
7.3.1 Overview
7.3.2 Hypertension: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
7.4.1 Overview
7.4.2 Diabetes: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
7.5.1 Overview
7.5.2 Hypercholestrolaemia: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet’s Disease
7.6.1 Overview
7.6.2 Behcet’s Disease: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
7.7.1 Overview
7.7.2 Obesity: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8. Middle East & Africa Endothelial Dysfunction Market Analysis – by Test Type
8.1 Overview
8.2 Middle East & Africa Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
8.3.1 Overview
8.3.2 Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
8.4.1 Overview
8.4.2 Non-Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.3 Flow Mediated Dilatory
8.4.3.1 Overview
8.4.3.2 Flow Mediated Dilatory: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.4 Venous Occlusion Plethysmography
8.4.4.1 Overview
8.4.4.2 Venous Occlusion Plethysmography: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.5 Peripheral Arterial Tonometry (PAT)
8.4.5.1 Overview
8.4.5.2 Peripheral Arterial Tonometry (PAT): Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.6 Circulating Markers
8.4.6.1 Overview
8.4.6.2 Circulating Markers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4.7 Others
8.4.7.1 Overview
8.4.7.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa Endothelial Dysfunction Market Analysis – by End User
9.1 Overview
9.2 Middle East & Africa Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
9.4.1 Overview
9.4.2 Diagnostics Centers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
9.5.1 Overview
9.5.2 Clinics: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa Endothelial Dysfunction Market – Revenue and Forecast to 2028 – Country Analysis
10.1 Middle East & Africa: Endothelial Dysfunction Market
10.1.1 Overview
10.1.1.1 Saudi Arabia: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Saudi Arabia: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.2 UAE: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 UAE: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.3 South Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 South Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
10.1.1.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
11. Middle East & Africa Endothelial Dysfunction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Endothelial Dysfunction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 ZOLL Medical Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 The Polymath Co
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Perimed AB
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 SMART Medical Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Medizinische Messtechnik GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
Table 3. Saudi Arabia Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)
Table 4. Saudi Arabia Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Saudi Arabia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 6. Saudi Arabia Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. UAE Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)
Table 8. UAE Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. UAE Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 10. UAE Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. South Africa Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)
Table 12. South Africa Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. South Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 14. South Africa Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of Middle East & Africa Endothelial Dysfunction Market, by Cause – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Middle East & Africa Endothelial Dysfunction Market, by Test Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Middle East & Africa Endothelial Dysfunction Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
Table 20. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
Table 21. Glossary of Terms, Endothelial dysfunction market
LIST OF FIGURES
Figure 2. Middle East & Africa Endothelial Dysfunction Market, by Country
Figure 3. Middle East & Africa Endothelial Dysfunction Market Overview
Figure 4. Hypertension Account for Largest Share of Cause Segment in Middle East & Africa Endothelial Dysfunction Market
Figure 5. South Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6. Middle East and Africa: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Middle East & Africa Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
Figure 9. Middle East & Africa Endothelial Dysfunction Market – Revenue Forecast and Analysis – 2020-2028
Figure 10. Middle East & Africa Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
Figure 11. Hypertension: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. Diabetes: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. Hypercholestrolaemia: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Behcet’s disease: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Obesity: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. Middle East & Africa Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
Figure 18. Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 19. Non-Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Flow Mediated Dilatory: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Venous Occlusion Plethysmography: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Peripheral Arterial Tonometry (PAT): Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Circulating Markers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Middle East & Africa Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
Figure 26. Hospitals and Clinics: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Diagnostics Centers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Clinics: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Middle East & Africa: Endothelial Dysfunction Market, by Key Country – Revenue (2022) (US$ Million)
Figure 31. Middle East & Africa: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 32. Saudi Arabia: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. UAE: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Middle East & Africa: Endothelial Dysfunction Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Growth Strategies in the Endothelial Dysfunction Market
The List of Companies – Middle East & Africa Endothelial Dysfunction Market
o Medizinische Messtechnik GmbH
o Perimed AB
o SMART Medical Ltd
o The Polymath Co
o ZOLL Medical Corp
You must be logged in to post a review.
Reviews
There are no reviews yet.